All Stories

  1. Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?
  2. Nanovesicles based drug targeting to control tumor growth and metastasis
  3. Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy
  4. Colorectal cancer: A comprehensive review based on the novel drug delivery systems approach and its management
  5. Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review
  6. Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus
  7. Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach
  8. NEXT GENERATION SEQUENCE ANALYSIS OF SEQUENCES FROM SRA FILE OF HIV-1 ENVELOPE PROTEIN.
  9. Computational elucidation of novel antagonists and binding insights by structural and functional analyses of serine hydroxymethyltransferase and interaction with inhibitors
  10. Leishmania donovani Inhibitor of Serine Peptidases 2 Mediated Inhibition of Lectin Pathway and Upregulation of C5aR Signaling Promote Parasite Survival inside Host
  11. Synthesis, Cytotoxic Evaluation, and Molecular Docking Studies of New Oxadiazole Analogues
  12. Computational elucidation, mutational and hot spot-based designing of potential inhibitors against human acid-sensing ion channels (hASIC-1a) to treat various physiological conditions
  13. Recent advancement and treatment of leishmaniasis based on pharmacoinformatics approach: Current and future outlook
  14. In silico identification of novel antagonists and binding insights by structural and functional analyses of guanylate kinase of Leishmania donovani and interaction with inhibitors
  15. Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis
  16. Role of inhibitors of serine peptidases in protecting Leishmania donovani against the hydrolytic peptidases of sand fly midgut
  17. Glucose-6-phosphate dehydrogenase and Trypanothione reductase interaction protects Leishmania donovani from metalloid mediated oxidative stress
  18. In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance
  19. Synthesis, Biological Evaluation and Molecular Docking Studies of Pyridine Incorporated Chalcone Derivatives as Anticancer Agents
  20. Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development
  21. Computational Elucidation of Structural Basis for Ligand Binding with Mycobacterium tuberculosis Glucose-1-Phosphate Thymidylyltransferase (RmlA)
  22. Design and synthesis of new 2,5-disubstituted-1,3,4-oxadiazole analogues as anticancer agents
  23. In vitro studies of the antileishmanial activity of the newer 2-(substitutedphenoxy)-N-[(aryl)methylidene]acetohydrazide analogues
  24. Antileishmanial activity of sulfonamide compound
  25. Universal minicircle sequence binding protein of Leishmania donovani regulates pathogenicity by controlling expression of cytochrome-b
  26. Development of PLGA–PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis
  27. Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors
  28. Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase
  29. Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review
  30. Computational elucidation of potential antigenic CTL epitopes in Ebola virus
  31. Synthesis, antiproliferative activity, and molecular docking studies of curcumin analogues bearing pyrazole ring
  32. Binding Pattern Elucidation of NNK and NNAL Cigarette Smoke Carcinogens with NER Pathway Enzymes: an Onco-Informatics Study
  33. Tuberculosis: Current Treatment, Diagnostics, and Newer Antitubercular Agents in Clinical Trials
  34. Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani
  35. Computational Identification of microRNA-like Elements in Leishmania major
  36. Structure, evolution and virtual screening of NDM-1 strain from Kolkata
  37. Molecular Modeling and Ligand-Protein Interaction of N-Protein of Chandipura Virus
  38. Spinigerin induces apoptotic like cell death in a caspase independent manner in Leishmania donovani
  39. Structure prediction of gBP21 protein ofL. donovaniand its molecular interaction
  40. Analysis of sequence, structure of GAPDH ofLeishmania donovaniand its interactions
  41. Computational Elucidation of Structural Basis for Ligand Binding with Leishmania donovani Adenosine Kinase
  42. Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMP